THIS IS WHAT WE’VE BEEN WAITING FOR!!!
RFK announced that in July the following peptides will be reviewed again and likely be allowed to be legally prescribed. Including several of my favorites:
BPC-157 - super healer
TB-500 - ligaments/tendon healer
GHK-Cu - skin, hair
MOTS-c - mitochondrial optimizer skeletal
Epithalon - brain/longevity reset
DSIP - deep sleep
Dihexa - brain optimizer, ⬇️ neuroinflam
Ibutamoren - oral growth hormone
Melanontan II - tanning, immune, sexual
KPV - anti-inflammatory
Semax - stroke, brain recovery,
LL-37 - fights virus, mold, Lyme, immune
I’ve been prescribing 10 (of 12) of these regularly since 2020.
There’s so many uses for these, and when used properly, they are VERY safe. Really good stacking protocols.
Likely by the late summer millions of Americans will have save access to these peptides through compounding pharmacies.
AMAZING NEWS‼️ 👏🏼
Today, we took long-overdue action to restore science, accountability, and the rule of law.
In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk.
Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence.
• BPC-157
• Thymosin beta-4 fragment (LKKTETQ)
• Epitalon
• GHK-Cu (injectable)
• MOTS-c
• DSIP (Emideltide)
• Dihexa Acetate
• Ibutamoren Mesylate
• Melanotan II
• KPV
• Semax (heptapeptide)
• Cathelicidin LL-37
This action begins to restore regulated access and will immediately begin shifting demand away from the black market.
We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.